A 4-Week Hep C Cure? Bristol to Test Drugs With Gilead's SovaldiA 4-Week Hep C Cure? Bristol to Test Drugs With Gilead's Sovaldi

In the race to find a faster cure for hepatitis C, Bristol-Myers Squibb Co said it will test its experimental antiviral drug combination with Gilead Sciences Inc's blockbuster drug Sovaldi (sofosbuvir). Reuters Health Information
Source: Medscape Gastroenterology Headlines - Category: Gastroenterology Tags: Infectious Diseases News Source Type: news